Active fragment of thymosin alphal and its polyethylene glycol derivatives
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
- Publication Date
- 2004-09-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to thymosin alpha substituted with natural or unnatural amino acids 1 Active fragments and their PEGylated derivatives, their preparation methods, their pharmaceutical compositions and their use in medicines for the treatment or prevention of diseases related to immunodeficiency and immunodeficiency, including hepatitis B, C Applications in the treatment or prevention of hepatitis, malignant melanoma, non-small cell lung cancer, SARS (severe acute respiratory syndrome) and other related diseases caused by coronavirus. Background technique
[0002] thymosin alpha 1 (Tα 1 ) is an important polypeptide secreted by the thymus. It is an immune enhancer for T lymphocytes, which can promote the maturation and differentiation of T cells, and promote the secretion of various lymphokines (such as interleukin-2 and γ - interferon, etc.), can also promote the generation of interleukin-2 receptor. Tα 1 It consists of 28 amino a...